Literature DB >> 7701865

Incidence of paratuberculosis after vaccination against M. paratuberculosis in two infected dairy herds.

G H Wentink1, J H Bongers, A A Zeeuwen, F H Jaartsveld.   

Abstract

Vaccination against paratuberculosis of all newborn animals has been performed since April 1984 in two dairy herds with a high incidence of clinical cases of paratuberculosis, using a vaccine containing heat-inactivated M. paratuberculosis in a water/mineral oil emulsion. Animals slaughtered between April 1984 and January 1991 were included in the study. Histology, bacterioscopy and culture on Smith and modified Löwenstein-Jensen media were performed using jejunum, ileum and draining lymph nodes. The animals present on the farm in April 1984 constituted a retrospective non-vaccinated group, giving an indication of the initial infection rate. After vaccination, the percentage of animals culled for clinical paratuberculosis decreased significantly (7.8 to 1.8%; P < 0.005), as did the percentage of animals with positive histology (11.8% to 5%). The incidence of infected animals, defined by positive results in histology and or bacterioscopy and/or culture, however, increased from 21.8% to 25.9%.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7701865     DOI: 10.1111/j.1439-0450.1994.tb00258.x

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  15 in total

Review 1.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

2.  Expression library immunization confers protection against Mycobacterium avium subsp. paratuberculosis infection.

Authors:  J F Huntley; J R Stabel; M L Paustian; T A Reinhardt; J P Bannantine
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection.

Authors:  A P Koets; V P Rutten; M de Boer; D Bakker; P Valentin-Weigand; W van Eden
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages.

Authors:  Aneesh Thakur; Claus Aagaard; Anders Stockmarr; Peter Andersen; Gregers Jungersen
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

5.  Postexposure subunit vaccination against chronic enteric mycobacterial infection in a natural host.

Authors:  Wiebren Santema; Victor Rutten; Ruud Segers; Jacqueline Poot; Selma Hensen; Hans Heesterbeek; Ad Koets
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

6.  Paratuberculosis control: a review with a focus on vaccination.

Authors:  Felix Bastida; Ramon A Juste
Journal:  J Immune Based Ther Vaccines       Date:  2011-10-31

7.  Immunoreactivity of the Mycobacterium avium subsp. paratuberculosis 19-kDa lipoprotein.

Authors:  Jason F J Huntley; Judith R Stabel; John P Bannantine
Journal:  BMC Microbiol       Date:  2005-01-21       Impact factor: 3.605

8.  Controlling Johne's disease: vaccination is the way forward.

Authors:  John P Bannantine; Adel M Talaat
Journal:  Front Cell Infect Microbiol       Date:  2015-01-21       Impact factor: 5.293

9.  Significant reduction in bacterial shedding and improvement in milk production in dairy farms after the use of a new inactivated paratuberculosis vaccine in a field trial.

Authors:  Ramon A Juste; Marta Alonso-Hearn; Elena Molina; Marivi Geijo; Patricia Vazquez; Iker A Sevilla; Joseba M Garrido
Journal:  BMC Res Notes       Date:  2009-11-22

10.  A novel multi-antigen virally vectored vaccine against Mycobacterium avium subspecies paratuberculosis.

Authors:  Tim J Bull; Sarah C Gilbert; Saranya Sridhar; Richard Linedale; Nicola Dierkes; Karim Sidi-Boumedine; John Hermon-Taylor
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.